REISTONE BIOPHARMA Trademark

Trademark Overview


On Monday, May 10, 2021, a trademark application was filed for REISTONE BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the REISTONE BIOPHARMA trademark a serial number of 90701198. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 24, 2023. This trademark is owned by Reistone Biopharma, Inc.. The REISTONE BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical or medical purposes, namely, for treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Therapeutic pharmaceutical for the treatment of autoim...
reistone biopharma

General Information


Serial Number90701198
Word MarkREISTONE BIOPHARMA
Filing DateMonday, May 10, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Therapeutic pharmaceutical for the treatment of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReistone Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRosemont, IL 60018

Party NameReistone Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRosemont, IL 60018

Trademark Events


Event DateEvent Description
Monday, July 24, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 24, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 9, 2022ASSIGNED TO LIE
Monday, July 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 18, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 18, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 19, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 19, 2022NON-FINAL ACTION WRITTEN
Thursday, January 13, 2022ASSIGNED TO EXAMINER
Tuesday, August 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 13, 2021NEW APPLICATION ENTERED